Oppenheimer & Co’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Oppenheimer & Co's TGTX Position: Q3 2026 in Review
Oppenheimer & Co reduced its TG Therapeutics (TGTX) stake by 0.05% in Q3 2026, selling an estimated $649 and leaving 26,002 shares worth $1.45M. The position accounts for 0.02% of the portfolio, ranked #759.
Oppenheimer & Co first reported a position in TGTX in Q1 2021 and has held it in 5 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Oppenheimer & Co held 26,002 shares of TG Therapeutics worth $1.45M as of Q3 2026.
- Oppenheimer & Co sold 12 TG Therapeutics shares in Q3 2026, an estimated $649.
- TG Therapeutics made up 0.02% of Oppenheimer & Co's portfolio in Q3 2026, its #759 holding.
- Oppenheimer & Co first reported a position in TG Therapeutics in Q1 2021 and has held it in 5 quarters since.
- 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.